A Double-Blind, Multi-Center, Randomized, Placebo Controlled Safety, Tolerability & Efficacy Trial Of A New Botanical Drug Product At One Dose Level For The Treatment Of Mild-To-Moderate Plaque Psoriasis In Adult Subjects
Phase of Trial: Phase II
Latest Information Update: 25 Jul 2017
At a glance
- Drugs Santalum album (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Santalis Pharmaceuticals
- 01 May 2017 Status changed from not yet recruiting to recruiting.
- 24 Apr 2017 Planned End Date changed from 1 Jul 2017 to 1 Oct 2017.
- 24 Apr 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Sep 2017.